Skip to main content
ScruticaAn open reference on AI compute

Company record

Intellia Therapeutics, Inc.

United States

Suppliers and customers

1 supplier, 3 customers

The customers with the most current records are Kyverna Therapeutics, NOVARTIS and Regeneron Pharmaceuticals.

Regeneron Pharmaceuticals is also recorded as a supplier.

Show

Suppliers

CompanyCountrySuppliesLatest record
Regeneron PharmaceuticalsunknownundisclosedFY2020a record of the past

Customers

CompanyCountryBuysLatest record
Kyverna TherapeuticsunknownundisclosedFY2022
NOVARTISunknownundisclosedFY2021
Regeneron PharmaceuticalsunknownundisclosedFY2024

Figures read 15 Nov 2026. Latest source 15 Nov 2026.

Sources, 2

Export-control designations
Federal Register-anchored designations0 records, 15 Nov 2026
Supply-chain relationships
SEC disclosures, re-derived company disclosures, licensed supply-chain database

How the figures were made

Suppliers and customers. Records are grouped by counterparty, and counterparties with more current records come first. A disclosure more than 5 years old is marked a record of the past and follows the current records with its fiscal year. A product or service appears only where the record’s cited source states it for the pair. Alternative suppliers may exist outside this corpus.

Identity. Variant identifiers are resolved to one organisation before its data is combined.

Identifiers

Scrutica ID
org-intellia-therapeutics-inc

Name forms resolved to this record: Intellia Therapeutics.